Eco-Friendly ingenuities are motivating huge growth in the industry of plant-based plastic packaging market. The industry is chiefly driven by eco-friendly characteristics of these plastic. North America is foretold to be the utmost reve…
BMI View: Namibia's weak domestic manufacturing capabilities and strong colonial ties with South Africa
will ensure the country continues to import the majority of its pharmaceutical needs over the coming years.
Despite a relatively attractive business environment, multinational drugmakers will continue to use South
Africa as the main channel trough which medicines are imported into the country, and will be unlikely to
establish a direct manufacturing presence. Local production of antiretroviral medicines will give a small
boost to the country's limited export potential.
Headline Expenditure Forecasts
- Pharmaceuticals: NAD2.34bn (USD183mn) in 2015 to NAD2.54bn (USD165mn) in 2016; +8.6% in
local currency and -10.0% in US dollar terms. Forecast virtually unchanged from last quarter.
- Healthcare: NAD14.3bn (USD1.12bn) in 2015 to NAD15.7bn (USD1.0bn) in 2016; +9.8% in local
currency and -9.0% in US dollar terms. Forecast in US dollar terms revised slightly upwards from last